Logo image of CHK

CHESAPEAKE ENERGY CORP (CHK) Stock Fundamental Analysis

USA - NASDAQ:CHK - US1651677353 - Common Stock

81.46 USD
-0.79 (-0.96%)
Last: 10/1/2024, 8:00:00 PM
81.46 USD
0 (0%)
After Hours: 10/1/2024, 8:00:00 PM
Fundamental Rating

5

CHK gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 211 industry peers in the Oil, Gas & Consumable Fuels industry. While CHK has a great health rating, its profitability is only average at the moment. CHK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CHK had positive earnings in the past year.
CHK had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CHK reported negative net income in multiple years.
CHK had a positive operating cash flow in each of the past 5 years.
CHK Yearly Net Income VS EBIT VS OCF VS FCFCHK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B -10B

1.2 Ratios

The Return On Assets of CHK (3.22%) is worse than 65.07% of its industry peers.
With a Return On Equity value of 4.22%, CHK is not doing good in the industry: 70.33% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 2.57%, CHK is doing worse than 75.60% of the companies in the same industry.
CHK had an Average Return On Invested Capital over the past 3 years of 13.76%. This is significantly below the industry average of 21.53%.
The 3 year average ROIC (13.76%) for CHK is well above the current ROIC(2.57%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 3.22%
ROE 4.22%
ROIC 2.57%
ROA(3y)35.26%
ROA(5y)-8.99%
ROE(3y)62.5%
ROE(5y)N/A
ROIC(3y)13.76%
ROIC(5y)9.96%
CHK Yearly ROA, ROE, ROICCHK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200 -200 -400 -600

1.3 Margins

Looking at the Profit Margin, with a value of 8.94%, CHK is in line with its industry, outperforming 40.67% of the companies in the same industry.
In the last couple of years the Profit Margin of CHK has grown nicely.
CHK has a worse Operating Margin (8.56%) than 69.86% of its industry peers.
CHK's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 78.39%, CHK belongs to the top of the industry, outperforming 88.52% of the companies in the same industry.
In the last couple of years the Gross Margin of CHK has remained more or less at the same level.
Industry RankSector Rank
OM 8.56%
PM (TTM) 8.94%
GM 78.39%
OM growth 3Y60.28%
OM growth 5Y26.63%
PM growth 3YN/A
PM growth 5Y88.94%
GM growth 3Y5.78%
GM growth 5Y0.58%
CHK Yearly Profit, Operating, Gross MarginsCHK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100 -100 -150

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CHK is creating some value.
The number of shares outstanding for CHK has been reduced compared to 1 year ago.
Compared to 5 years ago, CHK has more shares outstanding
Compared to 1 year ago, CHK has an improved debt to assets ratio.
CHK Yearly Shares OutstandingCHK Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
CHK Yearly Total Debt VS Total AssetsCHK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 5B 10B 15B

2.2 Solvency

An Altman-Z score of 4.46 indicates that CHK is not in any danger for bankruptcy at the moment.
CHK's Altman-Z score of 4.46 is amongst the best of the industry. CHK outperforms 85.17% of its industry peers.
CHK has a debt to FCF ratio of 9.53. This is a negative value and a sign of low solvency as CHK would need 9.53 years to pay back of all of its debts.
With a Debt to FCF ratio value of 9.53, CHK perfoms like the industry average, outperforming 43.06% of the companies in the same industry.
A Debt/Equity ratio of 0.19 indicates that CHK is not too dependend on debt financing.
CHK has a better Debt to Equity ratio (0.19) than 69.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 9.53
Altman-Z 4.46
ROIC/WACC0.33
WACC7.73%
CHK Yearly LT Debt VS Equity VS FCFCHK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B 10B

2.3 Liquidity

CHK has a Current Ratio of 2.16. This indicates that CHK is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CHK (2.16) is better than 73.21% of its industry peers.
A Quick Ratio of 2.16 indicates that CHK has no problem at all paying its short term obligations.
With a decent Quick ratio value of 2.16, CHK is doing good in the industry, outperforming 75.12% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.16
Quick Ratio 2.16
CHK Yearly Current Assets VS Current LiabilitesCHK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

4

3. Growth

3.1 Past

CHK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -74.81%.
Measured over the past years, CHK shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.65% on average per year.
The Revenue for CHK has decreased by -58.30% in the past year. This is quite bad
CHK shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.46% yearly.
EPS 1Y (TTM)-74.81%
EPS 3YN/A
EPS 5Y-8.65%
EPS Q2Q%-98.44%
Revenue 1Y (TTM)-58.3%
Revenue growth 3Y13.87%
Revenue growth 5Y-5.46%
Sales Q2Q%-73.29%

3.2 Future

The Earnings Per Share is expected to grow by 27.56% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 19.77% on average over the next years. This is quite good.
EPS Next Y-74.18%
EPS Next 2Y2.06%
EPS Next 3Y18.26%
EPS Next 5Y27.56%
Revenue Next Year-42.93%
Revenue Next 2Y20.29%
Revenue Next 3Y19.77%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CHK Yearly Revenue VS EstimatesCHK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5B 10B 15B 20B
CHK Yearly EPS VS EstimatesCHK Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 5 10 15 20

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 27.43, CHK can be considered very expensive at the moment.
CHK's Price/Earnings ratio is a bit more expensive when compared to the industry. CHK is more expensive than 70.81% of the companies in the same industry.
When comparing the Price/Earnings ratio of CHK to the average of the S&P500 Index (27.77), we can say CHK is valued inline with the index average.
CHK is valuated correctly with a Price/Forward Earnings ratio of 15.93.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CHK is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.23, CHK is valued a bit cheaper.
Industry RankSector Rank
PE 27.43
Fwd PE 15.93
CHK Price Earnings VS Forward Price EarningsCHK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CHK indicates a slightly more expensive valuation: CHK is more expensive than 63.16% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, CHK is valued a bit more expensive than the industry average as 64.59% of the companies are valued more cheaply.
Industry RankSector Rank
P/FCF 87.19
EV/EBITDA 10.11
CHK Per share dataCHK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

CHK's earnings are expected to grow with 18.26% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.06%
EPS Next 3Y18.26%

3

5. Dividend

5.1 Amount

CHK has a Yearly Dividend Yield of 2.82%.
Compared to an average industry Dividend Yield of 6.30, CHK has a dividend in line with its industry peers.
CHK's Dividend Yield is comparable with the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 2.82%

5.2 History

The dividend of CHK decreases each year by -27.58%.
CHK has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-27.58%
Div Incr Years0
Div Non Decr Years0
CHK Yearly Dividends per shareCHK Yearly Dividends per shareYearly Dividends per share 2015 2021 2022 2023 2024 10 20 30

5.3 Sustainability

CHK pays out 74.89% of its income as dividend. This is not a sustainable payout ratio.
DP74.89%
EPS Next 2Y2.06%
EPS Next 3Y18.26%
CHK Yearly Income VS Free CF VS DividendCHK Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5B -5B -10B
CHK Dividend Payout.CHK Dividend Payout, showing the Payout Ratio.CHK Dividend Payout.PayoutRetained Earnings

CHESAPEAKE ENERGY CORP

NASDAQ:CHK (10/1/2024, 8:00:00 PM)

After market: 81.46 0 (0%)

81.46

-0.79 (-0.96%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)07-29 2024-07-29/amc
Earnings (Next)10-29 2024-10-29/amc
Inst Owners69.55%
Inst Owner Change0.56%
Ins Owners34.93%
Ins Owner Change0%
Market Cap18.48B
Analysts75.83
Price Target97.71 (19.95%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.82%
Yearly Dividend3.66
Dividend Growth(5Y)-27.58%
DP74.89%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)228.74%
Min EPS beat(2)-6.54%
Max EPS beat(2)464.01%
EPS beat(4)3
Avg EPS beat(4)153.85%
Min EPS beat(4)-6.54%
Max EPS beat(4)464.01%
EPS beat(8)7
Avg EPS beat(8)90.83%
EPS beat(12)10
Avg EPS beat(12)68.05%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-20.53%
Min Revenue beat(2)-36.48%
Max Revenue beat(2)-4.59%
Revenue beat(4)2
Avg Revenue beat(4)7.45%
Min Revenue beat(4)-36.48%
Max Revenue beat(4)45.81%
Revenue beat(8)6
Avg Revenue beat(8)42.17%
Revenue beat(12)8
Avg Revenue beat(12)36.68%
Revenue beat(16)9
Avg Revenue beat(16)22.86%
PT rev (1m)-7.14%
PT rev (3m)-8.21%
EPS NQ rev (1m)-60.96%
EPS NQ rev (3m)-69.49%
EPS NY rev (1m)0%
EPS NY rev (3m)-18.9%
Revenue NQ rev (1m)-5.86%
Revenue NQ rev (3m)-17.02%
Revenue NY rev (1m)-2.47%
Revenue NY rev (3m)-6.44%
Valuation
Industry RankSector Rank
PE 27.43
Fwd PE 15.93
P/S 3.77
P/FCF 87.19
P/OCF 10.64
P/B 1.78
P/tB 1.78
EV/EBITDA 10.11
EPS(TTM)2.97
EY3.65%
EPS(NY)5.11
Fwd EY6.28%
FCF(TTM)0.93
FCFY1.15%
OCF(TTM)7.66
OCFY9.4%
SpS21.58
BVpS45.7
TBVpS45.7
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.22%
ROE 4.22%
ROCE 3.31%
ROIC 2.57%
ROICexc 2.79%
ROICexgc 2.79%
OM 8.56%
PM (TTM) 8.94%
GM 78.39%
FCFM 4.33%
ROA(3y)35.26%
ROA(5y)-8.99%
ROE(3y)62.5%
ROE(5y)N/A
ROIC(3y)13.76%
ROIC(5y)9.96%
ROICexc(3y)14.49%
ROICexc(5y)10.54%
ROICexgc(3y)14.49%
ROICexgc(5y)10.54%
ROCE(3y)17.73%
ROCE(5y)12.84%
ROICexcg growth 3Y17.67%
ROICexcg growth 5Y15.1%
ROICexc growth 3Y17.67%
ROICexc growth 5Y15.1%
OM growth 3Y60.28%
OM growth 5Y26.63%
PM growth 3YN/A
PM growth 5Y88.94%
GM growth 3Y5.78%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.36
Health
Industry RankSector Rank
Debt/Equity 0.19
Debt/FCF 9.53
Debt/EBITDA 1.05
Cap/Depr 101.13%
Cap/Sales 31.14%
Interest Coverage 4.46
Cash Conversion 90.14%
Profit Quality 48.4%
Current Ratio 2.16
Quick Ratio 2.16
Altman-Z 4.46
F-Score5
WACC7.73%
ROIC/WACC0.33
Cap/Depr(3y)99.31%
Cap/Depr(5y)100.4%
Cap/Sales(3y)17.38%
Cap/Sales(5y)20.06%
Profit Quality(3y)28.9%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.81%
EPS 3YN/A
EPS 5Y-8.65%
EPS Q2Q%-98.44%
EPS Next Y-74.18%
EPS Next 2Y2.06%
EPS Next 3Y18.26%
EPS Next 5Y27.56%
Revenue 1Y (TTM)-58.3%
Revenue growth 3Y13.87%
Revenue growth 5Y-5.46%
Sales Q2Q%-73.29%
Revenue Next Year-42.93%
Revenue Next 2Y20.29%
Revenue Next 3Y19.77%
Revenue Next 5YN/A
EBIT growth 1Y-91.23%
EBIT growth 3Y82.51%
EBIT growth 5Y19.71%
EBIT Next Year-4.53%
EBIT Next 3Y38.42%
EBIT Next 5Y39.9%
FCF growth 1Y-86.46%
FCF growth 3Y192.58%
FCF growth 5YN/A
OCF growth 1Y-37.25%
OCF growth 3Y26.92%
OCF growth 5Y6.59%